Targeting the immunological synapse in multiple myeloma.

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• The immunological synapse (IS) is vital for T-cell-mediated cytotoxicity against cancer cells.
• Therapeutic resistance in multiple myeloma (MM) involves complex factors including IS disruption and immune escape.
• The bone marrow (BM) niche in MM impairs T-cell function and synaptic integrity.

Purpose of the Study:

• To review the role of the IS in MM and its therapeutic potential.
• To examine how the MM niche disrupts IS function and explore strategies for restoration.
• To compare BiTEs and CAR-T cells in IS formation and function.

Main Methods:

• Literature review integrating mechanistic, translational, and clinical data.
• Analysis of synaptic structure, signaling, and therapeutic interventions.
• Comparison of existing and next-generation synapse-engineering strategies.

Main Results:

• The MM niche actively impairs IS function, contributing to therapeutic resistance.
• Bispecific T-cell engagers (BiTEs) and chimeric antigen receptor T-cells (CAR-Ts) modulate IS formation and function.
• Next-generation approaches aim to create more specific and resilient cytolytic junctions.

Conclusions:

• Engineering the immunological synapse is a promising strategy to overcome MM resistance.
• Understanding IS dynamics in the MM niche is key to developing effective immunotherapies.
• Future therapies focus on advanced synapse engineering for enhanced T-cell-mediated killing.